SOPHiA GENETICS SA Other Long-Term Assets 2020-2025 | SOPH

SOPHiA GENETICS SA other long-term assets from 2020 to 2025. Other long-term assets can be defined as field containing the sum of all non-current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
SOPHiA GENETICS SA Annual Other Long-Term Assets
(Millions of US $)
2024 $6
2023 $6
2022 $4
2021 $4
2020 $1
2019 $1
SOPHiA GENETICS SA Quarterly Other Long-Term Assets
(Millions of US $)
2025-03-31 $6
2024-12-31 $6
2024-09-30 $6
2024-06-30 $6
2024-03-31 $6
2023-12-31 $6
2023-09-30 $5
2023-06-30 $6
2023-03-31 $5
2022-12-31 $4
2022-09-30 $4
2022-06-30 $4
2022-03-31 $4
2021-12-31 $4
2021-09-30 $3
2021-06-30 $2
2021-03-31 $1
2020-12-31 $1
2020-09-30
2020-06-30
2020-03-31
2019-12-31 $1
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.212B $0.065B
SOPHiA GENETICS SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM(TM) Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. SOPHiA GENETICS SA is based in BOSTON.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.883B 59.65
Hims & Hers Health (HIMS) United States $14.668B 152.40
Doximity (DOCS) United States $11.054B 51.17
Tempus AI (TEM) United States $10.008B 0.00
IRhythm Technologies (IRTC) United States $4.472B 0.00
Inspire Medical Systems (INSP) United States $3.870B 60.47
Hinge Health (HNGE) United States $3.513B 0.00
Privia Health (PRVA) United States $2.388B 163.25
10x Genomics (TXG) United States $1.713B 0.00
Phreesia (PHR) United States $1.608B 0.00
Enovis (ENOV) United States $1.544B 8.61
Azenta (AZTA) United States $1.530B 71.11
Schrodinger (SDGR) United States $1.520B 0.00
Clover Health Investments (CLOV) United States $1.476B 0.00
Omnicell (OMCL) United States $1.391B 24.55
Evolent Health (EVH) United States $1.162B 99.00
Claritev (CTEV) United States $0.636B 0.00
Fulgent Genetics (FLGT) United States $0.532B 0.00
Standard BioTools (LAB) United States $0.524B 0.00
Veradigm (MDRX) United States $0.507B 0.00
Butterfly Network (BFLY) United States $0.448B 0.00
Talkspace (TALK) United States $0.418B 125.00
TruBridge (TBRG) United States $0.315B 698.67
Outset Medical (OM) United States $0.300B 0.00
Health Catalyst (HCAT) United States $0.256B 0.00
Nyxoah SA (NYXH) Belgium $0.243B 0.00
CapsoVision (CV) United States $0.190B 0.00
Zepp Health (ZEPP) Netherlands $0.175B 0.00
KORU Medical Systems (KRMD) United States $0.161B 0.00
Pulmonx (LUNG) United States $0.127B 0.00
EUDA Health Holdings (EUDA) Singapore $0.122B 0.00
American Well (AMWL) United States $0.117B 0.00
MDxHealth SA (MDXH) Belgium $0.115B 0.00
CareCloud (CCLD) United States $0.100B 3.81
ImmunoPrecise Antibodies (IPA) Canada $0.080B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.077B 0.00
111 (YI) China $0.060B 0.00
P3 Health Partners (PIII) United States $0.052B 0.00
HeartBeam (BEAT) United States $0.039B 0.00
Zhongchao (ZCMD) China $0.026B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.013B 0.00
Healthcare Triangle (HCTI) United States $0.012B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Strata Skin Sciences (SSKN) United States $0.008B 0.00
MSP Recovery (MSPR) United States $0.008B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.005B 0.00
Movano (MOVE) United States $0.005B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
PROFUSA (PFSA) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00